Condition: Oestrogen receptor positive breast cancer


rs140538758 in CBFB gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.

rs2981579 in FGFR2 gene and Oestrogen receptor positive breast cancer PMID 28864454 2017 Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.

rs6938753 in LINC02521;LINC01600 gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.

rs12998806 in LOC105373874;LOC101928278 gene and Oestrogen receptor positive breast cancer PMID 28171663 2016 In addition, we confirmed SNP rs10069690 was the best indicator for ER-negative breast cancer at 5p15.33 (OR = 1.30; P = 2.4 × 10 − 10) and identified rs12998806 as the best indicator for ER-positive breast cancer at 2q35 (OR = 1.34; P = 2.2 × 10 − 8) for women of African ancestry.

rs11251942 in LOC105376360 gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.

rs62235635 in PITPNB;TTC28-AS1;MIR3199-2 gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.

rs12938141 in RAP1GAP2 gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.

rs7082321 in SFMBT2 gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.

rs73370840 in SLC19A1;COL18A1 gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.

rs79116769 in SLC25A4 gene and Oestrogen receptor positive breast cancer PMID 30787463 2019 Genome-wide association study of germline variants and breast cancer-specific mortality.